What Happened?
Deerfield, IL-based Takeda Appointed Shibani Mitra-Kaushik as Head, Drug Product, Viral Vectors and Cell Bank Analytics-Cell Therapies
About the Company
For more than 235 years, Takeda has been serving society with innovative medicines, helping patients reclaim valuable moments of life from illness. Now, with new healthcare solutions from prevention to care and cure, we are determined to help even more people enjoy their lives to the fullest. Our mission is simple: we strive toward better health for patients worldwide through leading innovation in medicine. This mission: • Drives our research and development of prescription drugs • Promotes our commitment to social responsibility • Marks our growth and success At Takeda, our passion for healthcare and commitment to improving lives will enable us to make the next 230 years healthier and brighter for people around the world. Our robust product pipeline is focused on treating serious diseases and disorders, including bone and joint disorders, cardiovascular disease, central nervous system disorders, chronic kidney disease, diabetes, gastroenterology, gynecological disorders and infectious disease.
About the Person
Shibani Mitra-Kaushik is Head, Drug Product, Viral Vectors and Cell Bank Analytics-Cell Therapies at Takeda. Previously, Shibani held various senior HR leadership roles in the industry.
Info Source
News
Short Profile